Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts
about
Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.cAMP/PKA-mediated regulation of erythropoiesis.The RIIbeta regulatory subunit of protein kinase A binds to cAMP response element: an alternative cAMP signaling pathway8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats.Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol.8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells.PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion.Differential binding of cAMP-dependent protein kinase regulatory subunit isoforms Ialpha and IIbeta to the catalytic subunit.A mouse model for Carney complex.Growth inhibition of human ovarian cancer cells by differential modulation of protein Kinase a Isozymes
P2860
Q34979352-205807D6-E4B8-4E1D-B71A-B045AEA9C131Q35635556-1AE88F56-AEA3-4F86-AA65-570BEF2819E3Q36485628-4BF3D340-A5E1-4471-BDEF-58CC3D9E2816Q36641041-C0750A12-8BA4-4749-A4C2-2F50A975B7CAQ37249448-AD352769-6668-46CB-AD83-0E73DB013E5AQ40761338-49CFD6A0-F765-4A07-BD76-C472E19AE85AQ41441726-A55E7714-6497-4959-87E7-D2360ABC2D90Q42477692-C4513984-5EC9-458B-AA38-EAACA4A6E32CQ42518471-47BF1A16-3456-4DCD-811C-CF685C6180ECQ42828386-25091118-4983-4CFF-8FAD-39E7B0E70EF2Q45292704-D0E9B738-2451-47F0-8858-DFB28665A06BQ45878838-3AFBD3C8-E79C-4AA2-9EDC-4F1442CBE1D2Q46392337-5DB9625B-EBA2-40A9-BFCB-D29D547A8396Q52059498-DA598748-A446-45F9-8408-09688C914478Q58291444-90F798D6-D61F-4B32-9EB5-CC4EDD679E20
P2860
Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Point mutation of the autophos ...... revert transformed fibroblasts
@ast
Point mutation of the autophos ...... revert transformed fibroblasts
@en
Point mutation of the autophos ...... revert transformed fibroblasts
@nl
type
label
Point mutation of the autophos ...... revert transformed fibroblasts
@ast
Point mutation of the autophos ...... revert transformed fibroblasts
@en
Point mutation of the autophos ...... revert transformed fibroblasts
@nl
prefLabel
Point mutation of the autophos ...... revert transformed fibroblasts
@ast
Point mutation of the autophos ...... revert transformed fibroblasts
@en
Point mutation of the autophos ...... revert transformed fibroblasts
@nl
P2093
P2860
P356
P1476
Point mutation of the autophos ...... revert transformed fibroblasts
@en
P2093
A Cereseto
A Kondrashin
M Nesterova
Y S Cho-Chung
P2860
P304
10634-10638
P356
10.1073/PNAS.92.23.10634
P407
P577
1995-11-01T00:00:00Z